UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000046029
Receipt No. R000052493
Scientific Title The effect of reducing postoperative sore throat by zinc troche before surgery in general anesthesia with tracheal intubation in the beach chair position
Date of disclosure of the study information 2021/11/11
Last modified on 2021/11/10 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The effect of reducing postoperative sore throat by zinc troche before surgery in general anesthesia with tracheal intubation in the beach chair position
Acronym The effect of reducing postoperative sore throat by zinc troche before surgery in general anesthesia with tracheal intubation in the beach chair position
Scientific Title The effect of reducing postoperative sore throat by zinc troche before surgery in general anesthesia with tracheal intubation in the beach chair position
Scientific Title:Acronym The effect of reducing postoperative sore throat by zinc troche before surgery in general anesthesia with tracheal intubation in the beach chair position
Region
Japan

Condition
Condition Sore throat after tracheal intubation
Classification by specialty
Anesthesiology Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Postoperative sore throat occurs in 14.5-50% of patients with tracheal intubation. In recent years, zinc has been reported to be effective against oral disorders such as mouth ulcer caused by radiation therapy and chemotherapy. Hypothesize and test that zinc troches are effective for postoperative sore throat due to tracheal intubation in beach chairs
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes Incidence of sore throat

Degree of sore throat
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Zinc-containing candy administered 30 minutes before anesthesia
Interventions/Control_2 Zinc-free candy administration 30 minutes before anesthesia
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
100 years-old >=
Gender Male and Female
Key inclusion criteria 18 years old and over
ASA1-2
Those who undergo tracheal intubation in the beach chair position
Key exclusion criteria Preoperative sore throat
Upper respiratory tract inflammation
Immunodeficiency
Chronic smoker
History of head and neck surgery
History of intubation difficulty
Use of tetracycline or quinolone antibiotics
Zinc allergy
Target sample size 60

Research contact person
Name of lead principal investigator
1st name Tomoko
Middle name
Last name Kotera
Organization Osaka orthopedic Hospital
Division name department of anesthesiology
Zip code 553-0007
Address Obiraki,Hukusimaku,Osaka
TEL 0664631111
Email starbucks.tomo@gmail.com

Public contact
Name of contact person
1st name Tomoko
Middle name
Last name Kotera
Organization Osaka orthopedic Hospital
Division name department of anesthesiology
Zip code 553-0007
Address Obiraki,Hukusimaku,Osaka
TEL 0664631111
Homepage URL
Email starbucks.tomo@gmail.com

Sponsor
Institute Osaka orthopedic Hospital
Institute
Department

Funding Source
Organization Osaka orthopedic Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Osaka orthopedic Hospital
Address Obiraki,Hukusimaku,Osaka
Tel 0664631111
Email starbucks.tomo@gmail.com

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 大阪整形外科病院 (大阪府)

Other administrative information
Date of disclosure of the study information
2021 Year 11 Month 11 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2021 Year 10 Month 01 Day
Date of IRB
2021 Year 10 Month 01 Day
Anticipated trial start date
2021 Year 11 Month 12 Day
Last follow-up date
2022 Year 05 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 11 Month 10 Day
Last modified on
2021 Year 11 Month 10 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052493